GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shedir Pharma Group SpA (MIL:SHE) » Definitions » EPS (Basic)

Shedir Pharma Group SpA (MIL:SHE) EPS (Basic) : €0.54 (TTM As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shedir Pharma Group SpA EPS (Basic)?

Shedir Pharma Group SpA's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was €0.14. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.54.

Shedir Pharma Group SpA's EPS (Diluted) for the six months ended in Jun. 2024 was €0.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.54.

Shedir Pharma Group SpA's EPS without NRI for the six months ended in Jun. 2024 was €0.14. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was 0.54.

During the past 12 months, Shedir Pharma Group SpA's average EPS without NRIGrowth Rate was -2.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 13.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Shedir Pharma Group SpA's highest 3-Year average EPS without NRI Growth Rate was 28.80% per year. The lowest was -15.60% per year. And the median was 9.00% per year.


Shedir Pharma Group SpA EPS (Basic) Historical Data

The historical data trend for Shedir Pharma Group SpA's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shedir Pharma Group SpA EPS (Basic) Chart

Shedir Pharma Group SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
Get a 7-Day Free Trial 0.25 0.34 0.34 0.52 0.50

Shedir Pharma Group SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.43 0.10 0.40 0.14

Shedir Pharma Group SpA EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shedir Pharma Group SpA's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(5.699-0)/11.363
=0.50

Shedir Pharma Group SpA's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1.556-0)/11.430
=0.14

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shedir Pharma Group SpA  (MIL:SHE) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Shedir Pharma Group SpA EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Shedir Pharma Group SpA's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Shedir Pharma Group SpA Business Description

Traded in Other Exchanges
N/A
Address
95 - Piano di Sorrento, Via Bagnulo, Naples, ITA, 80063
Shedir Pharma Group SpA is engaged in manufacturing of nutraceuticals, cosmetics and medical devices. Its products are divided into four lines Shedir , Deimos, Phobos, and Menkar. The company's products include capsules, softgels, swallowable and chewable tablets, orosoluble powders, granules, oral solutions, drops for oral use, sprays for oral, sublingual and nasal use, Creams and gels for cosmetic use, and Spray for topical use.

Shedir Pharma Group SpA Headlines